Background: Thyroid dysfunction includes hyper- and hypofunction of the thyroid gland (hyperthyroidism and hypothyroidism). The spectrum encompasses both subclinical and clinical disease presentation. The etiology is vast and varied, as are the risk factors and simptoms. Objective: The main aim of the research is to indicate the leading symptom for initial thyroid hormone status evaluation, as well as to identify the distribution of positive and negative test results, and specific disorders according to sex and age groups. Methods: The research is designed as a retrospective, clinical, descriptive study. There were 500 participants included, 355 female and 145 male. Patients were referred to the Department of endocrinology by their primary care physicians. The data was collected through patient documentation. Results: The study included 500 participants, 71% of diagnostic requests made were for women. 80% of subjects had normal thyroid hormone status, p<0.001. Most requests were made for the 41-60 age group, p<0.001. Women had similar number of positive and negative test outcomes, as well as men. When it comes to the age groups, outcomes were similar in all of them, 15-23% positive and 77-85% negative. There were significant differences in the type of symptom expressed in both men and women, as well as all the age groups. Men reported high blood pressure as the most common symptom (30.3%), while women reported weight gain (22.3%). In the 18-25 and 26-40 age groups most common symptom belongs to the category of other. Age group of 41-60 reported weight gain as the most common symptom, while in participants older than 60, high blood pressure is proven to be the most common. Hypothyroidism is the most common disorder in both men and women, as well as in all age groups. Conclusion: It is statistically proven that there were more requests made for women, and older age groups. Leading symptom for initial thyroid hormone status evaluation is high blood pressure. There is no statistically significant difference in distribution of thyroid disorders according to sex or age groups.

Background/Aim: Until March 2023, it has been reported over 676 million cases of COVID-19 globally with almost 7 million deaths caused by this disease. Aim of this study was to determine COVID-19-related deaths and to study how COVID-19 pandemic impacted mortality of residents in the Canton of Sarajevo in 2020-2022 time period. Also, aim was to analyse to what extent the number of registered non-COVID-19-related deaths have changed in the Canton of Sarajevo compared to what would have been expected in the absence of the virus to better measure the impact of COVID-19. Methods: This study used mortality data obtained from Federal Institute for Statistics for period 2017-2022. Data was analysed and presented as raw numbers, age-, sex-, cause of death - crude death rates (CDR), excess mortality and P-score. Results: CDR in the Canton of Sarajevo in 2020 was 1246.3 per 100.000 persons, 1488.6 in 2021 and 1153.4 in 2022, while in period from 2017-2019 CDR ranged from 1051.3 to 1057.9. Total CDR in 2020 increased by 18.3 % compared to 2017-2019 average CDR, this relative difference being even greater in 2021 (41.3 %) and lower in 2022 (9.5 %). In 2020-2022 time period, 9 of the 10 leading causes of death remained the same as in 2019. COVID-19 was the 3rd leading cause of death in 2020 and 2022, while in 2021 spiked as the leading cause of death. In 2020 there was increase of 7 % in deaths from non-COVID-19 related deaths compared to mean number of deaths for period 2017-2019. As for 2021, this number goes higher (9.5 %) and in 2022 was much lower (1.0 %). Conclusion: In the Canton of Sarajevo, COVID-19 pandemic made a big impact on mortality in 2020-2022 years period. Data have changed in total mortality, leading causes of death and excess mortality. Deep-rooted organisational weaknesses that were exposed during pandemic that can bring harm to population from preventable chronic diseases needs to be addressed which have impact on morbidity and at the end, on mortality.